Search Results - "Neoadjuvant chemotherapy"

Efficacy of AC‐T Versus TAC Neoadjuvant Chemotherapy for Locally Advanced Breast Cancer: A Retrospective Analysis.

Authors: Mirzania, Mehrzad Anari, Fatemeh Emami, Seyed Amir Hossein et al.

Source: International Journal of Breast Cancer. 6/19/2026, Vol. 2026, p1-9. 9p.

To Study the Neutrophil Lymphocyte Ratio As a Predictive Marker of Response to Neoadjuvant Chemotherapy in Locally Advanced Triple-Negative Breast Cancer.

Authors: KN, Lokesh Aggarwal, Deepa SK, Pavan et al.

Source: Indian Journal of Medical & Paediatric Oncology. Jun2026, Vol. 47 Issue 3, p209-217. 9p.

Antibody–drug conjugate combined with chemoimmunotherapy: Redefining the neoadjuvant strategy for human epidermal growth factor receptor 2‐overexpressing locally advanced gastric cancer.

Authors: Nie, Shulun Wang, Cunliang Cao, Xiaolan et al.

Source: Clinical & Translational Discovery. Jun2026, Vol. 6 Issue 3, p1-5. 5p.

Early tumour size changes from neoadjuvant chemotherapy as a predictor of pathologic response in breast cancer.

Authors: Chung, Erika Z. Alberico, David Sannachi, Lakshmanan et al.

Source: PLoS ONE. 5/27/2026, Vol. 21 Issue 5, p1-15. 15p.

Baseline and Early-Delta Quantitative Ultrasound Radiomics for Predicting Pathologic Response to Neoadjuvant Chemotherapy in Breast Cancer.

Authors: Putin, Ramona Stanga, Livia Roșca, Ciprian Ilie et al.

Source: Journal of Clinical Medicine. May2026, Vol. 15 Issue 10, p3759. 15p.

Impact of Pharmacogenetic Markers on the Efficacy of Neoadjuvant FLOT Chemotherapy in Patients with Gastric and Gastroesophageal Junction Adenocarcinoma.

Authors: Fedorinov, Denis Lyadov, Vladimir Lyadova, Marina et al.

Source: International Journal of Molecular Sciences. May2026, Vol. 27 Issue 9, p4114. 10p.

Body Mass Index Does Not Predict High Miller–Payne Response to Neoadjuvant Chemotherapy in Stage II–III Breast Cancer: A Single-Center Retrospective Cohort Study of 647 Patients.

Authors: Acik, Hasan Arici, Serdar

Source: Journal of Clinical Medicine. May2026, Vol. 15 Issue 9, p3423. 12p.

Efficacy of Neoadjuvant Immunochemotherapy in Pulmonary Lymphoepithelioma Carcinoma Compared With Lung Squamous Cell Carcinoma and Adenocarcinoma: A Retrospective Cohort Study.

Authors: Sun, Weizhen Lin, Yaobin Zhou, Yuheng et al.

Source: Cancer Medicine. May2026, Vol. 15 Issue 5, p1-11. 11p.

Ruptured Wilms Tumor: Clinical Features, Diagnostic Challenges, and Survival Outcomes.

Authors: Emadeldeen, Hiba Ghandour, Khalil Al-Shamaileh, Tamador et al.

Source: Current Oncology. May2026, Vol. 33 Issue 5, p293. 12p.

A Consensus Approach to the Incorporation of Total Neoadjuvant Therapy in a Treatment Algorithm for Stage I–III Resectable Rectal Cancer.

Authors: Chadi, Sami A. Kazazian, Karineh Savage, Paul et al.

Source: Current Oncology. May2026, Vol. 33 Issue 5, p274. 19p.

Pretreatment Claudin-18.2 Expression Predicts Poorer Survival Outcomes in Locally Advanced Gastric Cancer Treated with Perioperative Chemotherapy.

Authors: Gül, Gürkan Kutlu, Özlem Argon, Asuman et al.

Source: Diagnostics (2075-4418). May2026, Vol. 16 Issue 9, p1277. 14p.

Vacuum‐Assisted Excision and Assessing Residual Tumor Burden in Patients With Breast Cancer Following Neoadjuvant Chemotherapy (A Pilot Study).

Authors: Hashemi, Hawzhin Olfatbakhsh, Asiie Moghadam, Shiva et al.

Source: International Journal of Breast Cancer. 4/25/2026, Vol. 2026, p1-7. 7p.

Research on Omitting Sentinel Lymph Node Biopsy after Neoadjuvant Therapy in cN1 Breast Cancer Patients.

Authors: Shang, Jiabei Chen, Jianzhe Zheng, Ruchun et al.

Source: Cancer Medicine. Apr2026, Vol. 15 Issue 4, p1-12. 12p.

Post‐Neoadjuvant Chemotherapy Axillary Ultrasound in cN+ Breast Cancer: Can It Reliably Support de‐Escalation of Axillary Surgery?

Authors: Albasini, Sara Rossetti, Camilla Brancaccio, Roberta et al.

Source: Cancer Medicine. Apr2026, Vol. 15 Issue 4, p1-9. 9p.

Curative resection of borderline resectable perihilar cholangiocarcinoma following neoadjuvant gemcitabine and cisplatin plus durvalumab immunochemotherapy: a case report.

Authors: Tanaka, Shogo Tsukuda, Hiroshi Okada, Takuma et al.

Source: Journal of Surgical Case Reports. Apr2026, Vol. 2026 Issue 4, p1-4. 4p.

Impact of Neoadjuvant Chemotherapy on Hormone Receptor Status and Systemic Inflammatory Markers in Breast Cancer Patients: A Retrospective Cohort Study.

Authors: KRISHNA, K. HARI SUPREETHA, M. S. SREERAMALU, P. N.

Source: Journal of Clinical & Diagnostic Research. Apr2026, Vol. 20 Issue 4, p74-79. 6p.

Inflammatory and Nutritional Indices as Prognostic Markers in Locally Advanced Gastric Cancer Treated with Neoadjuvant FLOT: A Retrospective Multicenter Study.

Authors: Yolcu, Süleyman Tuna Günaltılı, Murat Yolcu, Emine Ayaz et al.

Source: Journal of Clinical Medicine. Apr2026, Vol. 15 Issue 7, p2574. 16p.

Trends in Treatment and Perioperative Outcomes of Upper Tract Urothelial Carcinoma: The Evolving Role of Lymphadenectomy and Neoadjuvant Chemotherapy.

Authors: Bischoff, Robert Pyrgidis, Nikolaos Ebner, Benedikt et al.

Source: Journal of Clinical Medicine. Apr2026, Vol. 15 Issue 7, p2536. 12p.

可切除局部进展期结直肠癌的新辅助免疫 治疗.

Alternate Title: Neoadjuvant immunotherapy for resectable locally advanced colorectal cancer.

Authors: 罗振恺 孙宇 向仁伸 et al.

Source: Chinese Journal of Oncology. Apr2026, Vol. 48 Issue 4, p562-570. 9p.

전환수술, 언제 의뢰할까? 내과 의사의 관점.

Alternate Title: When Should We Refer for Conversion Surgery in Pancreatic Cancer? The Gastroenterologist's Perspective.

Authors: Jang, Dong Kee¹ (AUTHOR) mapmotive@hanmail.net

Source: Korean Journal of Pancreas & Biliary Tract / Daehan Chwedamdo Haghoeji. Apr2026, Vol. 31 Issue 2, p37-41. 5p.